Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

966.10INR
29 May 2015
Change (% chg)

Rs11.30 (+1.18%)
Prev Close
Rs954.80
Open
Rs964.45
Day's High
Rs979.00
Day's Low
Rs960.00
Volume
7,065,774
Avg. Vol
8,278,411
52-wk High
Rs1,200.80
52-wk Low
Rs581.85

SUN.NS

Chart for SUN.NS

About

Sun Pharmaceutical Industries Ltd. (Sun) is a specialty pharmaceutical company. The Company manufactures and markets a range of pharmaceutical formulations as branded generics, as well as generics, in the United States, India and other markets. It operates through four segments: US Generics, Indian Branded Generics, Internationa... (more)

Overall

Beta: 0.56
Market Cap(Mil.): Rs2,324,846.00
Shares Outstanding(Mil.): 2,406.42
Dividend: 1.50
Yield (%): 0.16

Financials

  SUN.NS Industry Sector
P/E (TTM): 33.75 36.11 38.09
EPS (TTM): 28.63 -- --
ROI: -- 16.12 15.45
ROE: -- 16.91 16.49
Search Stocks

Sun Pharma misses profit estimates on Ranbaxy costs

MUMBAI - Sun Pharmaceutical Industries Ltd, India's largest drugmaker by sales, reported fourth-quarter profit well below analysts' expectations, hit by costs related to integrating smaller rival Ranbaxy Laboratories Ltd.

29 May 2015

India's Sun Pharma misses profit estimates on Ranbaxy costs

MUMBAI, May 29 - Sun Pharmaceutical Industries Ltd , India's largest drugmaker by sales, reported fourth-quarter profit well below analysts' expectations, hit by costs related to integrating smaller rival Ranbaxy Laboratories Ltd.

29 May 2015

Indian court bars Glenmark from selling Merck drug copies

MUMBAI - India's Supreme Court has barred Glenmark Pharmaceuticals from making and selling copies of U.S. drugmaker Merck's diabetes drugs Januvia and Janumet, according to a court document released on Friday.

15 May 2015

UPDATE 1-Indian court bars Glenmark from selling Merck drug copies

MUMBAI, May 15 - India's Supreme Court has barred Glenmark Pharmaceuticals from making and selling copies of U.S. drugmaker Merck's diabetes drugs Januvia and Janumet, according to a court document released on Friday.

15 May 2015

Stock market sell-off wipes out 2015 gains; bonds falter

MUMBAI - The BSE Sensex and Nifty slumped more than 2 percent on Wednesday to wipe out their entire gains for the year because of strong selling on algorithmic trading platforms, while continued offloading by foreign investors amid retrospective tax worries also weighed.

06 May 2015

Sensex rises nearly 2 percent, Nifty marks best daily gain in two months

MUMBAI - Stock markets closed nearly 2 percent higher on Monday, with the Nifty posting its biggest daily gain in more than two months, as investors snapped up beaten down blue-chips after the Lok Sabha approved the 2015/16 Finance Bill on Thursday.

04 May 2015

Sensex falls to near four-month closing low

MUMBAI - Indian shares fell for the third straight week on Thursday to their lowest level in nearly four months, led by declines in blue chips as the monthly derivative contract expired.

30 Apr 2015

Sensex falls in cautious trade ahead of derivatives expiry

MUMBAI - The BSE Sensex fell on Wednesday, dragged down by heavyweights such as Housing Development and Finance Corp and Bharti Airtel after their quarterly earnings fell short of expectations.

29 Apr 2015

DEALTALK-Sun Pharma, not sated by Ranbaxy deal, may spend up to $7 bln on M&A -bankers

* Sun Pharma looking to buy overseas biosimilar assets - bankers

28 Apr 2015

BUZZ-India's Sun Pharma up; FTSE raises weight in index

** Sun Pharmaceutical Industries Ltd rises as much as 1.04 pct

27 Apr 2015

Earnings vs. Estimates

Search Stocks